SUO 2016: Evidence for colon cancer surveillance after resection and implications for urologic oncology - Session Highlights


San Antonio, Texas USA (UroToday.com) Scott Regenbogen, University of Michigan, discussed colon cancer surveillance in comparison to that used in urologic oncology.


Despite level one evidence in colorectal surgery there are limited risk stratification with infinite variations in surveillance modalities with evolving technology which makes guideline recommendations for surveillance recommendations challenging. Given the numerous risk factors associated with colorectal cancer and various imaging modalities it is increasingly difficult to provide ‘high level’ evidence to support the optimal surveillance strategy. Unfortunately, there have been reported no survival difference among those having more intense surveillance versus those that either have limited to no surveillance. In the OPRA trial assessing colorectal surveillance the results regarding surveillance were similar. Thus, while urologists may feel uncertain regarding surveillance strategies among urologic cancers we are not alone as illustrated by our colorectal colleagues.

Presented By: Scott Regenbogen, University of Michigan

Written By: Stephen B. Williams, MD and Ashish M. Kamat

17th Annual Meeting of the Society of Urologic Oncology - November 30 -December 2, 2016 – San Antonio, Texas USA
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe